Global Partnerships ACROBiosystems has established long-term collaborations with Pfizer, Novartis and Johnson & Johnson, supported by a global network of offices, R&D centers and production bases. This setup enables pursuit of multi-year reagent supply contracts and integrated development programs from discovery to clinical application, anchored by GMP capabilities. Sales opportunities include engaging global pharma R&D accounts and CROs for end-to-end reagent sourcing and services.

Full Portfolio The company offers recombinant proteins, kits, antibodies and scientific services with strict quality control across discovery, screening, CMC development, preclinical work and clinical application. The HEK293 functional cell lines licensing upgrade adds a licensing dimension to accelerate R&D and compliance. Target customers include biotech, pharma, and contract research organizations seeking integrated reagent and licensing solutions.

Global Footprint A twelve-city footprint across the United States, Europe and China combined with active participation in industry events such as Bio Korea and Innovation Day enables region-specific campaigns, on-site demonstrations and partnerships with local distributors or CROs to accelerate adoption.

Credible Positioning Recognized as a Protein Supplier to Watch in cancer research with partnerships to leading pharma and academic institutions, this credibility supports pursuing preferred vendor status and multi-year supply contracts in oncology research and diagnostics.

Innovative Partnerships Ongoing involvement in high-throughput biology collaborations and CGT solutions anchored by GMP capabilities creates opportunities for bundled reagent and service offerings for high-throughput screening, cell therapy, and gene therapy programs, including engagements with CROs and biotech startups.